Fragment–Based Lead Discovery Conference
Join WuXi AppTec at this year’s Fragment-Based Lead Discovery conference.
Fragment-based drug discovery is one of the most well-developed approaches for projects starting from small, low-affinity compounds. Powerful biophysical and structural biology tools enable the study of large numbers of fragments and are opening new possibilities in the treatment of various diseases.
WuXi AppTec offers a comprehensive fragment screening platform to support hit-to-lead optimization workflows. Together with our well-seasoned synthetic and medicinal chemistry platform, we incorporate multiple, advanced techniques for an integrated approach to fragment-based drug discovery. Our business and scientific leaders will be in attendance, and we welcome the opportunity to discuss your projects!
To learn more about our FBDD services platform, click HERE
Resource Links
Fragment-based Drug Discovery
Resource Type: Brochure
Covalent Fragment-based Drug Discovery: BTK Inhibitors
Resource Type: Latest Science
Addition of Covalent Warhead and DEL-Generated Hit Fragmentation Empower FBDD
Resource Type: Latest Science
